News

Press Releases

MBio Diagnostics, Inc. Presenting at Upcoming Conferences

-- Seeking Partners for its Portable On-the-Spot Testing Platform --

Boulder, CO, September 14, 2015 – MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, today announced that its CEO is presenting at two upcoming conferences. The first presentation will be at SCIENION’s “Workshop Series DIAGNOSTICS 5.0 – Partnering for Tomorrow’s Medical Care” conference in Berlin, Germany, on September 18, 2015. The second will be at the Rocky Mountain Life Science Investor & Partnering Conference in Vail, Colorado, on September 24, 2015.

 

The MBio test platform brings a remarkable simplicity and speed to a broad range of test modalities, from protein arrays to nucleic acid detection and cellular analysis. The simplicity is enabled by the MBio LightDeck® technology, based on planar waveguides and fluorescent detection. LightDeck® technology has applications in medical and veterinary diagnostics, food safety testing, and environmental monitoring.

“The opportunity to redefine how testing is done is vast, across multiple industries and applications,” said Chris Myatt, CEO of MBio Diagnostics. “Through these conferences, we seek to accelerate our partnering activities across multiple industries.”

‘DIAGNOSTICS SCIENION’s Workshop Series DIAGNOSTICS 5.0 – Partnering for Tomorrow’s Medical Care’ will focus on innovative developments in this exciting field, with presentations that explore new technical improvements and applications, future products and as well as pre-and post-market thought.

The Rocky Mountain Life Science Investor & Partnering Conference gives a preview of this industry’s future. Presenting companies span a range of sectors within the life science industry including, biologics, medical devices, drug delivery and diagnostics.

About the MBio Array System

The MBio Array System is a portable, easy-to-use multiplex reader that provides lab-quality results in 1 to 20 minutes employing low-cost, disposable load-and-go cartridges. The System utilizes patented LightDeck® planar waveguide technology that eliminates sample prep and can be designed to detect all key analytes including: proteins, cells, nucleic acids, and small molecules.

About MBio Diagnostics

MBio is leading a new era in rapid, on-the-spot clinical diagnostics and sample testing. Our portable MBio multiplex analyzer and disposable cartridge enable low-cost, rapid answers in 1 to 20 minutes. MBio aims to be the platform of choice for leading providers and users of clinical and analytical testing services in all market segments including: medical, veterinary, environmental, food, agricultural and military. www.mbiodx.com

Contacts

Company:
Chris Myatt
MBio Diagnostics, Inc.
Phone: 303-952-2815
Email: chris.myatt@mbiodx.com

Media:
Karen Sharma
MacDougall Biomedical Communications
Phone: 781-235-3060
Email: ksharma@macbiocom.com